» Articles » PMID: 10051603

Regulation of G1 Progression by the PTEN Tumor Suppressor Protein is Linked to Inhibition of the Phosphatidylinositol 3-kinase/Akt Pathway

Overview
Specialty Science
Date 1999 Mar 3
PMID 10051603
Citations 246
Authors
Affiliations
Soon will be listed here.
Abstract

PTEN/MMAC1 is a tumor suppressor gene located on chromosome 10q23. Inherited PTEN/MMAC1 mutations are associated with a cancer predisposition syndrome known as Cowden's disease. Somatic mutation of PTEN has been found in a number of malignancies, including glioblastoma, melanoma, and carcinoma of the prostate and endometrium. The protein product (PTEN) encodes a dual-specificity protein phosphatase and in addition can dephosphorylate certain lipid substrates. Herein, we show that PTEN protein induces a G1 block when reconstituted in PTEN-null cells. A PTEN mutant associated with Cowden's disease (PTEN;G129E) has protein phosphatase activity yet is defective in dephosphorylating inositol 1,3,4,5-tetrakisphosphate in vitro and fails to arrest cells in G1. These data suggest a link between induction of a cell-cycle block by PTEN and its ability to dephosphorylate, in vivo, phosphatidylinositol 3,4,5-trisphosphate. In keeping with this notion, PTEN can inhibit the phosphatidylinositol 3,4, 5-trisphosphate-dependent Akt kinase, a downstream target of phosphatidylinositol 3-kinase, and constitutively active, but not wild-type, Akt overrides a PTEN G1 arrest. Finally, tumor cells lacking PTEN contain high levels of activated Akt, suggesting that PTEN is necessary for the appropriate regulation of the phosphatidylinositol 3-kinase/Akt pathway.

Citing Articles

Inhibition of Src signaling induces autophagic killing of Toxoplasma gondii via PTEN-mediated deactivation of Akt.

Hubal A, Vendhoti A, Shaffer C, Vos S, Lopez Corcino Y, Subauste C PLoS Pathog. 2025; 21(1):e1012907.

PMID: 39869638 PMC: 11801697. DOI: 10.1371/journal.ppat.1012907.


Colquhounia root tablet improves diabetic kidney disease by regulating epithelial-mesenchymal transition via the PTEN/PI3K/AKT pathway.

Ma D, Zhang J, Du L, Shi J, Liu Z, Qin J Front Pharmacol. 2024; 15:1418588.

PMID: 39130629 PMC: 11310013. DOI: 10.3389/fphar.2024.1418588.


Akt is a mediator of artery specification during zebrafish development.

Zhou W, Ghersi J, Ristori E, Semanchik N, Prendergast A, Zhang R Development. 2024; 151(17).

PMID: 39101673 PMC: 11441982. DOI: 10.1242/dev.202727.


Inhibiting HSD17B8 suppresses the cell proliferation caused by PTEN failure.

Zhao W, Huang R, Ran D, Zhang Y, Qu Z, Zheng S Sci Rep. 2024; 14(1):12280.

PMID: 38811827 PMC: 11137105. DOI: 10.1038/s41598-024-63052-5.


Female-specific dysfunction of sensory neocortical circuits in a mouse model of autism mediated by mGluR5 and estrogen receptor α.

Molinaro G, Bowles J, Croom K, Gonzalez D, Mirjafary S, Birnbaum S Cell Rep. 2024; 43(4):114056.

PMID: 38581678 PMC: 11112681. DOI: 10.1016/j.celrep.2024.114056.


References
1.
Guldberg P, Thor Straten P, Birck A, Ahrenkiel V, Kirkin A, Zeuthen J . Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 1997; 57(17):3660-3. View

2.
Furnari F, Huang H, Cavenee W . The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 1998; 58(22):5002-8. View

3.
Kong D, Suzuki A, Zou T, Sakurada A, Kemp L, Wakatsuki S . PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet. 1997; 17(2):143-4. DOI: 10.1038/ng1097-143. View

4.
Rasheed B, Stenzel T, McLendon R, Parsons R, Friedman A, Friedman H . PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res. 1997; 57(19):4187-90. View

5.
Datta S, Dudek H, Tao X, Masters S, Fu H, Gotoh Y . Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997; 91(2):231-41. DOI: 10.1016/s0092-8674(00)80405-5. View